Stocks
Amylyx Pharmaceuticals (AMLX) EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | -13.4 | -38.7 | -82.7 | -201.3 | 39.9 | -80.1 | |
| Changes by years, y/y, % | +189% | +114% | +143% | -120% | ||||
Amylyx Pharmaceuticals. EBITDA US GAAP, bln rub
Amylyx Pharmaceuticals. EBITDA US GAAP, changes, %
Amylyx Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -2.05 | 20.5 | 19.0 | 2.24 | -121.8 | -80.1 | |
| Changes by years, y/y, % | -96% | -138% | -135% | -105% | +5 834% | |||
| Changes by quarters, q/q, % | -95% | -1 098% | -7% | -88% | -5 550% | |||
